INDUSTRY

 

​The Canadian cannabis market has developed into a fast-evolving and expanding sector that is predicted to exceed C$23-billion once the drug is legalized. This has largely been driven by the 2016 Access to Cannabis for Medical Purposes Regulations (ACMPR), the anticipated legalization of recreational cannabis in Canada by 2018 and the consequent accelerated awareness and demand for cannabis in Canada and globally.

Blakes has vast experience supporting clients entering new and developing areas in Canada. Combined with our expertise in the agribusiness and life sciences sectors, we are well-positioned to advise producers, retailers, financiers, technology providers and others servicing both medical and recreational opportunities in the cannabis market, as well as clients in other sectors whose businesses are impacted by the legalization of cannabis.

With respect to the pending changes to cannabis laws in Canada, the Blakes Cannabis group works closely with the Blakes Government & Public Sector team. With decades of experience, the Blakes Government & Public Sector team includes highly regarded lawyers who regularly represent both public entities and private companies dealing with the public sector. Our team also includes counsel who previously served as federal, provincial and municipal public officials in several jurisdictions. Blakes lawyers possess leading expertise regarding government and public-sector issues and maintain solid working relationships with an extensive network of government advocacy professionals and government contacts, enabling us to efficiently solve challenging issues as they arise.

The Blakes Cannabis group is a national and multidisciplinary group of lawyers with cannabis-specific experience and expertise. Our group is geared to providing clients with the full range of services required to navigate the fast-moving and evolving cannabis market in Canada. The group is comprised of lawyers who are able to advise on financing, public offerings, M&A, regulatory, advertising, labelling and marketing, licensing and regulation, antitrust, legislative process, lobbying compliance, real estate issues, environmental concerns, channel distribution, tax, international trade, anti-money laundering, outsourcing, class actions, employment law and workplace issues, information technology, and intellectual property matters related to plant breeders’ rights, patents, trade-marks, copyright, industrial designs, and trade secrets.
 
Representative Matters

Capital Markets

  • Horizons ETFs Management (Canada) Inc. in connection with the initial public offering of North America’s first marijuana exchange-traded fund, Horizons Medical Marijuana Life Sciences ETF.
  • TerrAscend, a vertically integrated cannabis company, in connection with its transformative private placement of common shares and warrants to JW Asset Management, Canopy Growth and Canopy Rivers.
  • Cannabis Growth Opportunity Corporation on all legal aspects of the initial public offering.
  • Cronos Group Inc. on offerings totalling $140-million of common shares.
  • An independent investment bank, in connection with a private placement of common shares by a global cannabis company and its related going-public transaction by way of a reverse take-over.

Corporate Commercial/M&A

  • Maricann Group Inc. in connection with a $42.5-million non-dilutive streaming transaction.

Financial Services

  •  A major Canadian bank on the financing of a licensed producer of medical marijuana, including regulatory landscape, industry risks and financing considerations specific to the cannabis industry.latory landscape, industry risks and financing considerations specific to the cannabis industry.
  • A licensed producer of medical marijuana in connection with risk mitigation and other anti-money laundering controls in relation to providing the producer with banking services.

Marketing & Regulatory

  • Computershare Trust Company of Canada on regulatory advice about cannabis and corporate trust services.
  • Various licensed producers of medical marijuana on regulatory matters (including security requirements, pesticides, use of online portals for medical documents, patient registration issues), marketing (including the sale of ancillary products as well as cannabis) and advertising (including use of social media).
  • Various clients in the health-care industry on initiatives and programs with patients or physicians, health-care compliance (including interactions with physicians and clinics), clinical trials, privacy, anti-spam, antitrust, as well as consumer complaint, recall and product liability matters.
  • Various ancillary businesses on the sale of products in the cannabis industry, including regulatory and marketing and advertising issues.
 

 PEOPLE

 
Page: 0 of 0              Items per page: 25 | 50 | ALL
No Data
Page: 0 of 0              Items per page: 25 | 50 | ALL